Table 4.

Comparison between the studied groups regarding the adverse effects.

	Groups			X2	P-value
	Group A	Group B	Group C
Headache	30 (32.6%)	12 (13.1%)	39 (43.8%)	6.7	0.036
Flushing	27 (29.3%)	1 (0.9%)	40 (44.9%)	16	<0.001
Palpitation	6 (6.5%)	4 (4.3%)	6 (6.7%)	2.09	0.351
Dizziness	21 (22.8%)	21 (23%)	20 (22.4%)	0.0	1.0
Nausea	27 (29.3%)	33 (36.2%)	38 (42.7%)	1.14	0.563
Fatigue	15 (16.3%)	18 (19.8%)	21 (23.6%)	0.41	0.812